We use cookies to collect anonymous data to help us improve your site browsing
experience.
Click 'Accept all cookies' to agree to all cookies that collect anonymous data.
To only allow the cookies that make the site work, click 'Use essential cookies only.' Visit 'Set cookie preferences' to control specific cookies.
A report from a rapid process evaluation of the introduction of Buvidal opiate substitution therapy in prisons in Scotland as a contingency measure response to the COVID-19 pandemic between May and September 2020.